ADMT ADM TRONICS UNLIMITED, INC.
Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 849401 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.0%
TTM net income YoY-8.3%
TTM EPS YoY—
Revenue 3-yr CAGR1.7%
Net income 3-yr CAGR—
Margins
Gross margin42.6%
Operating margin-4.4%
Net margin-4.3%
FCF margin—
EBITDA margin-4.2%
Returns
ROE-17.3%
ROA-6.7%
ROIC (approx.)-20.8%
Asset turnover1.57x
Leverage & solvency
Liabilities / assets63.6%
Debt / equity0.00x
Current ratio1.08x
Interest coverage-4.10x
Cash quality & payout
Operating cash flow / net income0.80x
Accruals ratio-1.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-09-30 | 2026Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2025Q22025-09-30 | 2025Q12025-06-30 | 2025Q4*2025-03-31 | 2024Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $941,671 | $866,255 | $682,821 | $803,088 | $887,498 | $973,675 | $749,719 | $749,510 |
| Cost of revenue | $432,783 | $471,205 | $456,983 | $530,592 | $511,701 | $492,382 | $561,923 | $481,331 |
| Gross profit | $508,888 | $395,050 | $225,838 | $272,496 | $375,797 | $481,293 | $187,796 | $268,179 |
| R&D expense | $121,546 | $103,267 | $142,428 | $180,214 | $96,740 | $125,589 | $116,692 | $161,005 |
| SG&A expense | $240,692 | $312,438 | $269,853 | $176,723 | $276,504 | $246,470 | $194,282 | $196,443 |
| Operating income | $146,650 | -$20,655 | -$186,443 | -$84,441 | $2,553 | $109,234 | -$123,178 | -$89,269 |
| Interest expense | $7,030 | $6,870 | $14,034 | $7,424 | $7,659 | $7,671 | $14,701 | $8,331 |
| Pretax income | $140,661 | $34,364 | -$198,480 | -$114,856 | -$114,672 | $329,134 | -$104,860 | -$237,177 |
| Income tax | $0 | $2,000 | $0 | $0 | $0 | $1,500 | $500 | $500 |
| Net income | $140,661 | $32,364 | -$198,480 | -$114,856 | -$114,672 | $327,634 | -$104,860 | -$237,677 |
| EBITDA | $148,287 | -$19,015 | -$184,773 | -$82,759 | $4,277 | $110,975 | -$121,057 | -$87,871 |
| EPS (basic) | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — | 0.00 |
| EPS (diluted) | — | — | — | 0.00 | — | — | — | 0.00 |
| Banking | ||||||||
| Provision for credit losses | — | — | — | — | — | — | $0 | $0 |
| Balance sheet | ||||||||
| Cash & equivalents | $204,410 | $222,619 | $255,730 | $298,733 | $321,224 | $369,790 | $382,969 | $430,700 |
| Receivables | $647,398 | $604,061 | $515,660 | $559,801 | $551,708 | $556,803 | $528,383 | $374,153 |
| Inventory | $370,951 | $347,071 | $250,624 | $341,433 | $368,157 | $388,970 | $336,270 | $445,110 |
| Current assets | $1.24M | $1.19M | $1.02M | $1.20M | $1.25M | $1.33M | $1.25M | $1.26M |
| Intangibles | $4,973 | $6,609 | $8,250 | $9,920 | $11,602 | $13,326 | $15,067 | $17,188 |
| Total assets | $2.05M | $2.02M | $1.83M | $2.05M | $2.16M | $2.39M | $2.13M | $2.15M |
| Current liabilities | $1.14M | $1.24M | $1.05M | $1.06M | $1.02M | $1.11M | $1.15M | $1.04M |
| Total liabilities | $1.30M | $1.42M | $1.26M | $1.29M | $1.28M | $1.39M | $1.46M | $1.37M |
| Shareholders' equity | $743,997 | $603,336 | $570,972 | $761,211 | $880,424 | $995,096 | $671,346 | $775,174 |
| Shares outstanding | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M | 67.59M |
| Cash flow statement | ||||||||
| Operating cash flow | -$18,361 | -$32,959 | -$41,244 | -$19,533 | -$63,282 | -$14,800 | $520,911 | -$73,022 |
| Investing cash flow | — | $0 | $0 | $0 | $0 | $0 | -$564,250 | $0 |
| Financing cash flow | $152 | -$152 | -$1,759 | -$2,958 | -$84 | $1,621 | -$4,392 | $75,945 |
| Depreciation & amortization | $1,637 | $1,640 | $1,670 | $1,682 | $1,724 | $1,741 | $2,121 | $1,398 |
| Stock-based compensation | — | — | $0 | $0 | $0 | $0 | $1,032 | $1,032 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.